11 research outputs found

    Modification of argon impurity transport by electron cyclotron heating in KSTAR H-mode plasmas

    Get PDF
    Experiments with a small amount of Ar gas injection as a trace impurity were conducted in the Korea Superconducting Tokamak Advanced Research (KSTAR) H-mode plasma (BT  = 2.8 T, IP = 0.6 MA, and PNBI = 4.0 MW). 170 GHz electron cyclotron resonance heating (ECH) at 600 and 800 kW was focused along the mid-plane with a fixed major radial position of R  =  1.66 m. The emissivity of the Ar16+ (3.949 Å) and Ar15+ (353.860 Å) spectral lines were measured by x-ray imaging crystal spectroscopy (XICS) and a vacuum UV (VUV) spectrometer, respectively. ECH reduces the peak Ar15+ emission and increases the Ar16+ emission, an effect largest with 800 kW. The ADAS-SANCO impurity transport code was used to evaluate the Ar transport coefficients. It was found that the inward convective velocity found in the plasma core without ECH was decreased with ECH, while diffusion remained approximately constant resulting in a less-peaked Ar density profile. Theoretical results from the NEO code suggest that neoclassical transport is not responsible for the change in transport, while the microstability analysis using GKW predicts a dominant ITG mode during both ECH and non-ECH plasmas

    Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

    Get PDF
    BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

    Development of two-channel prototype ITER vacuum ultraviolet spectrometer with back-illuminated CCD and micro-channel plate detectors

    No full text
    A vacuum ultraviolet (VUV) spectrometer of a five-channel spectral system is designed for ITER main plasma impurity measurement. To develop and verify the system design, a two-channel prototype system is fabricated with No. 3 (14.4-31.8 nm) and No. 4 (29.0-60.0 nm) among the five channels. The optical system consists of a collimating mirror to collect the light from source to slit, two holographic diffraction gratings with toroidal geometry, and two different electronic detectors. For the test of the prototype system, a hollow cathode lamp is used as a light source. To find the appropriate detector for ITER VUV system, two kinds of detectors of the back-illuminated charge-coupled device and the microchannel plate electron multiplier are tested, and their performance has been investigated
    corecore